Aethlon Medical Inc的Hemopurifier®设备在澳大利亚进行的肿瘤学临床试验中展现出积极效果,研究结果显示该设备能够改变患者体内的细胞外囊泡、细胞外微RNA以及T细胞的数量水平。
Aethlon Medical Inc的Hemopurifier®设备在澳大利亚进行的肿瘤学临床试验中展现出积极效果,研究结果显示该设备能够改变患者体内的细胞外囊泡、细胞外微RNA以及T细胞的数量水平。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.